Graminex
Graminex is a third-generation, family-owned US manufacturer of solvent-free flower pollen extracts, vertically integrated across 6,500 acres of Ohio farmland and a cGMP facility, supplying standardized raw materials, finished supplements, and contract manufacturing to pharmaceutical, nutraceutical, food, animal health, and cosmetics customers globally.
- Company typePrivate
- Founded1940
- HeadquartersSaginaw, United States
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
What Graminex does
Graminex, L.L.C. is a privately held, family-owned American manufacturer of solvent-free flower pollen extracts, founded in 1940 and operating across three generations. The company is vertically integrated from certified seed through 6,500 acres of family-owned farmland in northwest Ohio, custom harvesting, controlled storage, proprietary solvent-free extraction, and finished product manufacturing at a 75,000 ft2 cGMP-certified facility in Deshler, Ohio. Its core intellectual property is a proprietary extraction process that isolates both water-soluble (G60) and lipid-soluble (NAX) pollen fractions and recombines them into a clinical-grade raw material (G63) without residual solvents, in contrast to competitor AB Cernelle's Cernilton/Cernitol products. The product portfolio spans standardized raw materials (G63, G60, NAX, RCT Fem Meno and UI, Pangenine) and finished consumer supplements (PollenAid, Prostanex, PollenBerry, Pollimmune, plus greens tablets), targeting prostate, urinary, immune, liver, menopause, and skin health indications, supported by 35+ human clinical studies.
Graminex sells into five distinct end markets — pharmaceuticals, nutraceuticals, functional food and beverage, animal health (via the Graminex Animal Health equine supplement line), and cosmetics/skin care (via Pangenine licensed into Pollenique) — through a B2B sales-led motion with direct manufacturer sales, custom formulation, contract solid-dose manufacturing, and private labeling services. It also operates a small D2C retail presence via Amazon (US) and iHerb (international), and runs an event-driven demand generation function across Vitafoods Europe, SupplySide Global, CHFA NOW Toronto, Hi Korea, NASC, and Petfood Forum. The company's revenue mix combines one-time raw material sales, contract manufacturing services, consumer finished goods, and ingredient licensing royalties.
Geographically, Graminex is anchored in the United States with regulatory-approved distribution into Canada (Health Canada FSRN and NNHPD approvals) and a wholly-owned regional subsidiary, Graminex Korea Co., Ltd., established in Seoul in August 2017 to serve Korea and the broader Asia-Pacific market. The company holds organic, kosher, pareve, and halal certifications alongside cGMP. All shareholding is internal; there are no recorded external funding rounds, parent company, or public listing.
Graminex firmographics
Firmographics- Name
- Graminex
- Legal name
- Graminex L.L.C.
- Website
- https://graminex.com
- Company type
- Private
- Founded year
- 1940
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Graminex is a third-generation, family-owned US manufacturer of solvent-free flower pollen extracts, vertically integrated across 6,500 acres of Ohio farmland and a cGMP facility, supplying standardized raw materials, finished supplements, and contract manufacturing to pharmaceutical, nutraceutical, food, animal health, and cosmetics customers globally.
- Ownership category
- akta.pro rank
Graminex industry classification
Industry- Product category
- Botanical Extracts / Nutraceutical Ingredients
- SIC
- Medicinal Chemicals & Botanical Products (2833), Agricultural Production-Crops (100)
- akta.pro primary industry
- Medicinal Plant Farming (Botanical/Pharmaceutical Crops) (AFAGAGAE)
Keywords
Where Graminex is headquartered
LocationHeadquarters
- HQ city
- Saginaw
- HQ country
- United States
- HQ region
- North America
Offices3 records
Markets served
Graminex business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Operations, Personnel, Infrastructure, Marketing or Sales, Technology or R&D
Revenue model
- Raw Materials Sales: Sale of raw pollen extract materials (G63, G60, NAX, RCT Fem products) to manufacturers and formulators in pharmaceutical, nutraceutical, food, and cosmetic industries. Bulk ordering with private labeling options available.
- Finished Products: Sale of finished consumer products including PollenAid, Prostanex, PollenBerry, Pollimmune, and greens tablets. Consumer retail through Amazon (US) and iHerb (international).
- Contract Manufacturing: Custom powder formulation, solid dose manufacturing (tablets and capsules), and finished packaging services. Turnkey solutions for Flower Pollen Extract formulations including smaller trial runs and private labeling.
- Licensing: Pollenique skin care products utilize Pangenine as key ingredient, indicating licensing arrangement for the flower pollen extract ingredient in external brand formulations.
Go-to-market motion3 records
Distribution channels4 records
Marketing channels4 records
Graminex product offering
Product offeringCore offering
Graminex grows, harvests, and extracts solvent-free Flower Pollen Extracts on 6,500 acres of family-owned Ohio farmland and sells standardized raw materials (G63, G60, NAX, RCT Fem Meno/UI, Pangenine) to nutraceutical, pharmaceutical, food, cosmetic, and animal health manufacturers. It also markets its own finished consumer supplements (PollenAid, Prostanex, PollenBerry, Pollimmune, greens tablets) and offers custom powder formulation, solid dose manufacturing, and private label packaging services.
Product overview
Graminex® is a company specializing in solvent-free Flower Pollen Extracts™ with a vertically integrated operation spanning 6,500 acres of family-owned farmland in Ohio. The product portfolio consists of raw materials (G63®, G60®, NAX™, RCT Fem™ Meno, RCT Fem™ UI, Pangenine®) and finished consumer products (PollenAid®, Prostanex®, PollenBerry®, Pollimmune®, Alfalfa Tablets, Barley Grass Tablets, Wheatgrass Tablets). The company also offers manufacturing services (Custom Powders, Solid Dose Manufacturing, Finished Packaging) and maintains an animal health division (Graminex Animal Health) for equine supplements. Products are backed by over 35 human clinical studies supporting prostate health, urinary function, immune health, liver support, and menopausal support.
Differentiator
Problem solved
Functional benefit
Brands
- Graminex G63: Clinically supported raw material containing both water-soluble and lipid-soluble pollen fractions in a 20:1 ratio.
- Graminex G60
- Graminex NAX
- PollenAid
- Prostanex
- PollenBerry
- Pollimmune
- Pangenine
Products and services
- Graminex G63 Flower Pollen Extract
Quantifiable outcome
- 35+ human clinical studies supporting safety and efficacy
- +2 more outcomes
Companies that use Graminex
Customer profileSegments7 records
Ideal customer profiles5 records
Graminex technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature5 records
Graminex partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- PolleniquecorePollenique skin care products utilize Pangenine flower pollen extract as their key active ingredient. Graminex licenses its proprietary Pangenine ingredient for use in premium skin care formulations.
Scale indicators6 records
Recent moves7 records
Expansion highlights6 records
Graminex competitors and assessment
Company assessmentDirect peers
- Standard Process: Whole food supplement manufacturer using glandular and plant-derived ingredients including pollen. Operates vertical integration from farm through manufacturing, similar to Graminex, and sells through practitioner and D2C channels targeting similar health indications.
- Indena: Italian manufacturer of standardized botanical extracts for pharmaceutical and nutraceutical applications. Highly comparable to Graminex in serving B2B ingredient customers with clinically supported plant extracts standardized to specific actives, with similar regulatory dossiers across multiple indications.
- AB Cernelle: Swedish producer of Cernilton rye pollen extract, explicitly named as Graminex's main competitor in the pollen extract market. Both companies manufacture botanical extracts from rye grass pollen targeting similar health indications including prostate health.
- Sabinsa: Manufacturer of standardized botanical extracts for the nutraceutical, pharmaceutical, and food industries. Comparable to Graminex as a B2B ingredient supplier serving manufacturers with clinically supported, plant-based ingredients standardized to active compounds across multiple health indications.
- Euromed: Spanish producer of standardized botanical extracts for nutraceutical and pharmaceutical industries. Directly comparable to Graminex as a B2B ingredient manufacturer serving supplement brands with plant-derived actives and standardized specifications.
Broad incumbents
- Life Extension: Premium supplement brand selling prostate health, urinary health, and other nutraceutical products through D2C channels. Comparable to Graminex finished products in serving the same consumer health indications with clinically-oriented formulations at premium price points.
- Naturex (Givaudan): Major botanical extract and natural ingredient supplier now part of Givaudan. Offers broader portfolio of plant extracts, colors, and functional ingredients across nutraceutical, food, and cosmetic categories — overlapping with Graminex but at much larger scale and broader product scope.
- NOW Foods: Large supplement manufacturer selling pollen-based and prostate health products (among thousands of SKUs) through mass-market and natural product channels. Sells comparable pollen-based formulations as part of a much broader supplement portfolio.
- Jarrow Formulas: Supplement brand selling prostate health, urinary tract health, and other nutraceutical products through retail and D2C channels. Comparable to Graminex in addressing the same health indications (notably prostate and urinary tract health) with science-oriented formulations.
- Kemin Industries: Diversified ingredient manufacturer serving nutrition, food, animal nutrition, and personal care markets with plant-derived ingredients. Overlaps with Graminex's vertical ingredient-supply model but operates at much broader scope including a substantial animal nutrition business that overlaps with Graminex Animal Health.
Market position
Strengths5 records
Weaknesses4 records
Competitive moat4 records
Key risks5 records
Key highlights6 records
Customer concentration
Graminex social profiles
Digital presenceGraminex financial estimates
Financial estimateRevenue estimate
Valuation estimate
Graminex leadership team
Management profileNumber of profiles
Graminex subsidiaries and ownership
Company hierarchySubsidiaries2 records
Graminex funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Graminex M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Graminex
What does Graminex do?
Graminex grows, harvests, and extracts solvent-free Flower Pollen Extracts on 6,500 acres of family-owned Ohio farmland and sells standardized raw materials (G63, G60, NAX, RCT Fem Meno/UI, Pangenine) to nutraceutical, pharmaceutical, food, cosmetic, and animal health manufacturers. It also markets its own finished consumer supplements (PollenAid, Prostanex, PollenBerry, Pollimmune, greens tablets) and offers custom powder formulation, solid dose manufacturing, and private label packaging services.
Is Graminex a public or private company?
Graminex is a private company. It is classified as family owned and is currently operating.
When was Graminex founded?
Graminex was founded in 1940. It employs 11 to 50 people.
Where is Graminex based?
Graminex is headquartered in Saginaw, United States, in the North America region.
How does Graminex make money?
Four revenue lines are on record. Raw Materials Sales are the primary driver. The others are finished Products, contract Manufacturing and licensing.
Who are Graminex's main competitors?
Direct peers on record are Standard Process, Indena, AB Cernelle, Sabinsa and Euromed. Broad incumbents are Life Extension, Naturex (Givaudan), NOW Foods, Jarrow Formulas and Kemin Industries.
Does Graminex have an API?
No public API is recorded for Graminex.
What industry is Graminex in?
Graminex's product category is Botanical Extracts / Nutraceutical Ingredients. Its primary akta.pro industry code is AFAGAGAE, Medicinal Plant Farming (Botanical/Pharmaceutical Crops). Its SIC code is 2833.